Literature DB >> 1464636

Stability of cisplatin in ethylene vinylacetate portable infusion-pump reservoirs.

E Rochard1, D Barthes, P Courtois.   

Abstract

The stability of cisplatin in admixture stored in portable pump reservoirs was investigated. Admixtures containing 0.9 or 0.5 mg/ml cisplatin in 0.9% sodium chloride injection were placed in 80-ml ethylene vinylacetate (EVA) drug reservoirs protected from light and 1-ml quantities were withdrawn immediately after preparation and after storage for 1, 2, 3, 4, 7, 14, 28 days at +22 or +35 degrees C. Three samples for each condition from each admixture were tested for drug concentration using a stability-indicating high-performance liquid chromatographic method. No colour change or precipitation was observed, and pH values were stable for the duration of the study. Loss of water through the reservoirs was substantial only when stored at +35 degrees C for 28 days. Cisplatin is stable in the infusion fluid used for 28 days under all the storage conditions considered.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1464636     DOI: 10.1111/j.1365-2710.1992.tb01310.x

Source DB:  PubMed          Journal:  J Clin Pharm Ther        ISSN: 0269-4727            Impact factor:   2.512


  3 in total

1.  Evaluation of Cisplatin Efficacy on HepG2 and E. coli Cells under Acidic Conditions

Authors:  Faezeh Babaei; Hasan Ebrahimi Shahmabadi; Mohammad Reza Rajabi; Hamed Haddad Kashani; Fatemeh Izadpanah
Journal:  Asian Pac J Cancer Prev       Date:  2019-03-26

2.  Effect of different shielding conditions on the stability of Cisplatin.

Authors:  Tomoya Abe; Daigo Matsumoto; Toshiaki Nakayama; Yukinari Shimazaki; Atsunobu Sagara; Dan Kanehira; Takuya Azechi; Fumiaki Sato; Hiroyasu Sakai; Tetsuro Yumoto; Junzo Kamei
Journal:  J Pharm Health Care Sci       Date:  2020-03-11

3.  The physical and chemical stability of cisplatin (Teva) in concentrate and diluted in sodium chloride 0.9%.

Authors:  Agnieszka Karbownik; Edyta Szałek; Hanna Urjasz; Aleksandra Głęboka; Emilia Mierzwa; Edmund Grześkowiak
Journal:  Contemp Oncol (Pozn)       Date:  2012-11-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.